Journal article icon

Journal article

Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: Outcomes from TECOS.

Abstract:

Objective

To evaluate chronic kidney disease (CKD) and cardiovascular outcomes in TECOS participants with type 2 diabetes and cardiovascular disease treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i), according to baseline estimated glomerular filtration rate (eGFR).

Research Design and Methods

We used data from 14,671 TECOS participants assigned double-blind to receive sitagliptin or placebo added to existing therapy, whilst aiming for glycemic...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.2337/dc16-1415

Authors


Cornel, JH More by this author
Bakris, GL More by this author
Stevens, SR More by this author
Alvarsson, M More by this author
Expand authors...
Merck Sharp & Dohme More from this funder
Publisher:
American Diabetes Association Publisher's website
Journal:
Diabetes Care Journal website
Publication date:
2016-10-05
Acceptance date:
2016-09-16
DOI:
ISSN:
1935-5548
Pubs id:
pubs:652836
URN:
uri:b4cc8e73-d090-47ef-bef6-32671899764b
UUID:
uuid:b4cc8e73-d090-47ef-bef6-32671899764b
Local pid:
pubs:652836
Language:
English
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP